Stock exchanges & markets

Overview Watchlists

Eli Lilly expects USD4.2 billion acquired R&D charge

8. Oct 2026

(AWP Alliance News) - Eli Lilly & Co - Indianapolis, Indiana-based pharmaceutical company - Says it expects its results for the third quarter of 2026 to include acquired pretax intellectual property research and development charges of USD4.2 billion. Says this represents a charge of USD4.57 per share. Says its results for the quarter ended September 30 have not been finalised and may differ from the preliminary figures. Adds that it does not forecast acquired charges due to uncertainty of occurrence, magnitude and timing.

Current stock price: USD1,169.60

12-month change: up 38%

By Harvey Dorset, Alliance News reporter

Comments and questions to newsroom [at] alliancenews.com

Copyright 2026 Alliance News Ltd. All Rights Reserved.

Learn more about our offers

  • Keep a close eye on your favourite shares

    Watchlist

    Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

    Sign up now

  • Compare ETFs systematically

    ETF Compass

    Find the products that suit your investment goals.

    Try the ETF Compass

  • How to find the best shares

    theScreener

    Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

    Test now